Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
出版年份 2022 全文链接
标题
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 1605-1620
出版商
Informa UK Limited
发表日期
2022-05-30
DOI
10.2147/dddt.s360346
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease
- (2021) Zhaoxia Xu et al. Cell Death & Disease
- Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation
- (2021) Hui Feng et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in db/db Mice
- (2021) Qilin Zhang et al. Oxidative Medicine and Cellular Longevity
- Signaling Pathways Involved in Diabetic Renal Fibrosis
- (2021) Yuqing Zhang et al. Frontiers in Cell and Developmental Biology
- Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy
- (2020) Lei Du et al. ACTA PHARMACOLOGICA SINICA
- Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells
- (2020) Ya-Ning Wang et al. BIOSCIENCE REPORTS
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
- (2020) Hong Wang et al. Frontiers in Pharmacology
- Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
- (2020) Yudi Zhang et al. Oxidative Medicine and Cellular Longevity
- Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis
- (2020) Xiao-Tao Zhou et al. PHARMACOLOGICAL RESEARCH
- Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis
- (2019) Xiaolei Wang et al. Scientific Reports
- PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
- (2019) Yajuan Li et al. JOURNAL OF CLINICAL INVESTIGATION
- C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/β-catenin and ERK signaling in streptozocin-induced diabetic nephropathy
- (2019) Lin Zhang et al. FASEB JOURNAL
- FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis
- (2019) Dongdong Fu et al. Frontiers in Immunology
- A Nucleoside/Nucleobase-Rich Extract from Cordyceps Sinensis Inhibits the Epithelial–Mesenchymal Transition and Protects against Renal Fibrosis in Diabetic Nephropathy
- (2019) Zhonghua Dong et al. MOLECULES
- Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
- (2019) Yuyan Fan et al. BMC Complementary and Alternative Medicine
- Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells
- (2018) Jihong Zhu et al. PHYTOTHERAPY RESEARCH
- Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
- (2018) Mei Xue et al. International Journal of Biological Sciences
- Projecting ESRD Incidence and Prevalence in the United States through 2030
- (2018) Keith P. McCullough et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression
- (2018) Yong Su et al. Pharmacological Reports
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway
- (2016) Ting He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy
- (2016) Hengjiang Guo et al. Frontiers in Pharmacology
- Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
- (2015) Rachana Shah et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
- (2015) Maria Perez-Gomez et al. Journal of Clinical Medicine
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
- (2014) Jianguo Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice
- (2013) K. H. Song et al. DIABETOLOGIA
- Activated innate immunity and the involvement of CX3CR1–fractalkine in promoting hematuria in patients with IgA nephropathy
- (2012) Sharon N. Cox et al. KIDNEY INTERNATIONAL
- Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
- (2011) LQ Meng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
- (2011) R. Shah et al. DIABETES
- BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
- (2011) Eleni Makrodouli et al. Molecular Cancer
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Tumor-promoting functions of transforming growth factor-β in progression of cancer
- (2011) Kohei Miyazono et al. UPSALA JOURNAL OF MEDICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now